货号:GS40683
Sutimlimab is a humanized monoclonal antibody targeting complement component 1s (C1s), a serine protease in the classical complement pathway. It inhibits C1s to block downstream complement activation, reducing hemolysis and inflammation. It is approved for the treatment of cold agglutinin disease (CAD), a rare autoimmune hemolytic anemia.
科技型中小企业
高新技术企业
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯